Companies / Elicio Therapeutics, Inc.

Elicio Therapeutics, Inc.

Nasdaq: ELTXCIK 1601485BOSTON, MA

Financials · FY2022

Revenue$2.30M
Net income$-39.57M
Total debt$9.54M
Cash$23.48M
Diluted EPS$-2.58
Shares outstanding19.1M

Ownership

19.1M shares outstanding · as of May 8, 2026
1.2%Insiders
Ownership
Insiders1.17%223,494
Institutions17.10%3,263,526
Public float81.73%15,599,061

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 4

View all →
Insider% of sharesShares
Connelly RobertCEOCEO, President and Director · Director
0.63%120,570
Haqq ChristopherSee Remarks
0.30%57,381
Shah PreetamSee Remarks
0.13%24,000
DeMuth PeterChief Scientific Officer
0.11%21,543

Institutional holders 42

View all →
HolderValue% of shares
Knoll Capital Management, LLC$6.74M3.31%
Vanguard Group Inc$3.96M2.60%
BlackRock, Inc.$3.00M4.01%
Balyasny Asset Management L.P.$2.62M1.28%
Geode Capital Management, LLC$1.45M0.71%
Renaissance Technologies LLC$1.30M0.64%
Millennium Management LLC$991.6K0.49%
Marshall Wace, LLP$796.5K0.39%
State Street Corporation$701.5K0.94%
Susquehanna International Group, LLP$509.9K0.34%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Feb 2, 2026Connelly Robert
CEO
GrantCommon Stock$0+74K
+156.70%
120,570
0.63% of shares
low
Feb 2, 2026Shah Preetam
Executive
GrantCommon Stock$0+24K
24,000
0.13% of shares
low
Feb 2, 2026Haqq Christopher
Executive
GrantCommon Stock$0+25K
+79.42%
57,381
0.30% of shares
low
Feb 2, 2026DeMuth Peter
Executive
GrantCommon Stock$0+21K
+2799.46%
21,543
0.11% of shares
low
Feb 2, 2026Connelly Robert
CEO
GrantStock Option (Right to Buy)—+147K
147,200
0.77% of shares
low
Feb 2, 2026Shah Preetam
Executive
GrantStock Option (Right to Buy)—+48K
47,900
0.25% of shares
low
Feb 2, 2026Haqq Christopher
Executive
GrantStock Option (Right to Buy)—+51K
50,900
0.27% of shares
low
Feb 2, 2026DeMuth Peter
Executive
GrantStock Option (Right to Buy)—+42K
41,600
0.22% of shares
low

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
ELTXCommon StockEquity28657F103BBG00444GM02